Dopamine (D1) receptor activation and nitrinergic agents influence somatostatin levels in rat retina

Experimental Eye Research

Volumn 86, Issue 1, 2008, Pages 18-24

  Kiagiadaki, Foteini ^a   Koulakis, Emmanuel ^a   Thermos, Kyriaki ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

8 Br cGMP; arginine; D1 D2 dopamine receptor ligands; SIN 1

Indexed keywords

1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN; 8 BROMO CYCLIC GMP; APOMORPHINE; ARGININE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NITRIC OXIDE; QUINPIROLE; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RELEASE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RETINA; SIGNAL TRANSDUCTION; VISION;

ANIMALS; APOMORPHINE; ARGININE; CYCLIC GMP; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RETINA; SOMATOSTATIN; TISSUE CULTURE TECHNIQUES;

EID: 36849070472     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.09.001     Document Type: Article

References (54)

1. Bigiani A., Petrucci C., Ghiaroni V., Dal Monte M., Cozzi A., Kreienkamp H.J., Richter D., and Bagnoli P. Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res. 29 1025 (2004) 177-185
2. Bloomfield S.A., and Dowling J.E. Roles of aspartate and glutamate in synaptic transmission in rabbit retina. I. Outer plexiform layer. J. Neurophysiol. 53 (1985) 699-713
3. Bloomfield S.A., and Dowling J.E. Roles of aspartate and glutamate in synaptic transmission in rabbit retina. I. Inner plexiform layer. J. Neurophysiol. 53 (1985) 714-725
4. Bohme E., Graf H., and Schultz G. Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP-formation in smooth muscle and platelets. Adv. Cyclic Nucleotide Res. 9 (1978) 131
5. Bohn H., and Schonafinger K. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J. Cardiovasc. Pharmacol. 14 Suppl. 11 (1989) 6-12
6. Brandstatter J.H., Koulen P., and Wassle H. Diversity of glutamate receptors in the mammalian retina. Vision Res. 38 (1998) 1385-1397
7. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J., and Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973) 77-79
8. Bugnon O., Schaad N.C., and Schorderet M. Nitric oxide modulates endogenous dopamine release in bovine retina. Neuroreport 5 (1994) 401-404
9. Carabelli V., D'AscenzoCarbone E., and Grassi C. Nitric oxide inhibits neuroendocrine Ca(V)1 L-channel gating via cGMP-dependent protein kinase in cell-attached patches of bovine chromaffin cells. J. Physiol. 541 (2002) 351-366
10. Cristiani R., Fontanesi G., Casini G., Petrucci C., Viollet C., and Bagnoli P. Expression of somatostatin subtype 1 receptor in the rabbit retina. Investig. Ophthalmol. Vis. Sci. 41 (2000) 3191-3199
11. Dal Monte M., Petrucci C., Vasilaki A., Cervia D., Grouselle D., Epelbaum J., Kreienkamp H.J., Richter D., Hoyer D., and Bagnoli P. Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology 45 (2003) 1080-1092
12. Ding J.D., and Weinberg R.J. Distribution of soluble guanylyl cyclase in rat retina. J. Comp. Neurol. 502 (2007) 734-745
13. Djamgoz M.B., Cunningham J.R., Davenport S.L., and Neal M.J. Nitric oxide inhibits depolarization-induced release of endogenous dopamine in the rabbit retina. Neurosci. Lett. 198 (1995) 33-36
14. Dowling J.E., and Ehinger B. Synaptic organization of the dopaminergic neurons in the rabbit retina. J. Comp. Neurol 180 (1978) 203-220
15. Feelish M., Ostrowski J., and Noack E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14 Suppl. 11 (1989) 13-22
16. 2A) receptors expression in the rabbit retina. Dev. Brain Res. 123 (2000) 67-80
17. Goldstein I.M., Ostwald P., and Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res. 36 (1996) 2979-2994
18. Gray D.B., Polo-Parada L., Pilar G.R., Eang P., Metzger R.R., Klann E., and Meriney S.D. A nitric oxide/cyclic GMP-dependent protein kinase pathway alters transmitter release and inhibition by somatostatin at a site downstream of calcium entry. J. Neurochem. 72 (1999) 1981-1990
19. Greenstreet E.H., and Djamgoz M.B. Nitric oxide induces light-adaptive morphological changes in retinal neurones. Neuroreport 6 (1994) 109-112
20. Guimaraes C.A., Assreuy J., and Linden R. Paracrine neuroprotective effect of nitric oxide in the developing retina. J. Neurochem. 76 (2001) 1233-1241
21. 2 in the rat retina. Investig. Ophthalmol. Vis. Sci. 40 (1999) 2376-2382
22. Hoyer D., Bell G.I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P.P., O'Carroll A.M., Patel Y.C., Schonbrunn A., Taylor J.E., and Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 16 (1995) 86-88
23. Huie R.E., and Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 18 (1993) 195-199
24. Huppé-Gourgues F., Coudé G., Lachapelle P., and Casanova C. Effects of the intravitreal administration of dopaminergic ligands on the b-wave amplitude of the rabbit electroretinogram. Vision Res. 45 (2005) 137-145
25. Kebabian J.W., Briggs C., Britton D.R., Asin K., DeNinno M., MacKenzie R.G., McKelvy J.F., and Schoenleber R. A68930: a potent and specific agonist for the D-1 dopamine receptor. Am. J. Hypertens. 3 (1990) 40S-42S
26. 2+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J. 13 (1994) 3312-3320
27. Kouvidi E., Papadopoulou-Daifoti Z., and Thermos K. Somatostatin modulates dopamine release in rat retina. Neurosci. Lett. 391 (2006) 82-86
28. Kramer S.G. Dopamine: A retinal neurotransmitter. I. Retinal uptake, storage and light-stimulated release of [3H] dopamine in vivo. Investig. Ophthalmol. Vis. Sci. 10 (1971) 438-452
29. McDonald L.J., and Murad F. Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med. 211 (1996) 1-6
30. 1) modulates the release of somatostatin in rat retina. Neurosci. Lett. 6 356 (2004) 13-16
31. 2) regulate cGMP production in rat retina. Regul. Pept. 133 (2006) 41-46
32. Meller E., Helmer-Matyjek E., Bohmaker K., Adler C.H., Friedhoff A.J., and Goldstein M. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists. Eur. J. Pharmacol. 123 (1986) 311-314
33. Mereu G., Collu M., Ongini E., Biggio G., and Gessa G.L. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. Eur. J. Pharmacol. 111 (1985) 393-396
34. Mori M., Ahara M., and Shimizu T. Differential expression of somatostatin receptors in the rat eye: SSTR4 is intensely expressed in the iris/ciliary body. Neurosci. Lett. 223 (1997) 185-188
35. Nguyen-Legros J., Versaux-Botteri C., and Vernier P. Dopamine receptor localization in the mammalian retina. Mol. Neurobiol. 19 (1999) 181-204
36. Ohkuma S., and Katsura M. Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the CNS. Prog. Neurobiol. 64 (2001) 97-108
37. Okada M., Osumi Y., Okuma Y., and Ueno H. Nitric oxide inhibits the release of acetylcholine in the isolated retina. Graefe's Arch. Clin. Exp. Ophthalmol. 239 (2001) 217-221
38. Palmer R.M., Rees D.D., Ashton D.S., and Moncada S. l-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153 (1988) 1251-1256
39. 2+ entry through store-operated channels. Brain Res. 1023 (2004) 243-252
40. Schrammel A., Pfeiffer S., Schmidt K., Koesling D., and Mayer B. Activation of soluble guanylyl cyclase by the nitrovasodilator 3-morpholinosydnonimine involves formation of S-nitrosoglutathione. Mol. Pharmacol. 54 (1998) 207-212
41. Schroder H., Ney P., Woditsch I., and Schror K. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur. J. Pharmacol. 182 (1990) 211-218
42. Seeman P., and Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15 (1994) 264-270
43. Sekaran S., Cunningham J., Neal M.J., Hartell N.A., and Djamgoz M.B. Nitric oxide release is induced by dopamine during illumination of the carp retina: serial neurochemical control of light adaptation. Eur. J. Neurosci. 21 (2005) 2199-2208
44. Shapiro B., Kronheim S., and Pinistone B. The presence of immunoreactive somatostatin in the rat retina. Horm. Metab. Res. 11 (1979) 79-80
45. Sperk S., and Widmann R. Somatostatin precursor in the rat striatum: changes after local injection of kainic acid. J. Neurochem. 45 (1985) 1441-1447
46. Thermos K. Functional mapping of somatostatin receptors in the retina: a review. Vision Res. 43 (2003) 1805-1815
47. 2 receptors in the rat retina. Neuropharmacology 43 (2002) 899-909
48. 2) are coupled to Go and modulate GTPase activity in the rabbit retina. J. Neurochem. 84 (2003) 625-632
49. Veruki M.L., and Wässle H. Immunohistochemical localization of dopamine D1 receptors in rat retina. Eur. J. Neurosci. 8 (1996) 2286-2297
50. Veruki M.L. Dopaminergic neurons in the rat retina express dopamine D2/3 receptors. Eur. J. Neurosci. 9 (1997) 1096-1100
51. Witkovsky P., and Schutte M. The organization of dopaminergic neurons in vertebrate retinas. Vis. Neurosci 7 (1991) 113-124
52. Witkovsky P. Dopamine and retinal function. Doc. Opthalmol. 108 (2004) 17-40
53. Yu D., and Eldred W.D. Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina. J. Comp. Neurol. 483 (2005) 278-291
54. Zalutsky R.A., and Miller R.F. The physiology of somatostatin in the rabbit retina. J. Neurosci. 10 (1990) 383-393